Trial Profile
An observational study Based on the Swedish National Quality Registry to determine Clincal Effectiveness of Golimumab in Crohn'S Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Apr 2019
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 06 Dec 2017 New trial record
- 01 Nov 2017 Results presented at the 25th United European Gastroenterology Week